Charles Link
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Tryptophan and brain disorders 14
- Oncology 12
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Nicholas N. Vahanian (22 shared papers)Richard K. Burt (6 shared papers)Hyo S. Han (4 shared papers)Roohi Ismail‐Khan (4 shared papers)Hatem Soliman (3 shared papers)Daniel M. Sullivan (2 shared papers)Scott Antonia (3 shared papers)Susan Minton (2 shared papers)
- Journals
- Cancer Research (4 papers)Oncotarget (3 papers)Neuro-Oncology (3 papers)European Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Charles Link
39 papers receiving 954 citations
Peers
Comparison fields: 5 of 87
- Biological Psychiatry 241
- Oncology 391
- Behavioral Neuroscience 47
- Immunology 277
- Reproductive Medicine 96
Countries citing papers authored by Charles Link
This map shows the geographic impact of Charles Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Link more than expected).
Fields of papers citing papers by Charles Link
This network shows the impact of papers produced by Charles Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Link. The network helps show where Charles Link may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Link, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 152 | |
| 2 | 2014 | 138 | |
| 3 | 2016 | 116 | |
| 4 | 2004 | 80 | |
| 5 | 2020 | 41 | |
| 6 | 2003 | 36 | |
| 7 | 2007 | 35 | |
| 8 | 2020 | 33 | |
| 9 | 2017 | 31 | |
| 10 | 2015 | 29 | |
| 11 | 1996 | 27 | |
| 12 | 2020 | 26 | |
| 13 | 2014 | 25 | |
| 14 | 2006 | 20 | |
| 15 | 2016 | 20 | |
| 16 | 2004 | 19 | |
| 17 | 2000 | 17 | |
| 18 | 1987 | 17 | |
| 19 | 2015 | 14 | |
| 20 | 2019 | 13 |
About Charles Link
Charles Link is a scholar working on Biological Psychiatry, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Immunology, having authored 40 papers that have together received 983 indexed citations. Recurring topics across this work include Tryptophan and brain disorders (14 papers), Cancer-related cognitive impairment studies (6 papers), Virus-based gene therapy research (5 papers), Cancer Research and Treatments (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Biological Psychiatry (241 citations), Oncology (391 citations), Behavioral Neuroscience (47 citations), Immunology (277 citations) and Reproductive Medicine (96 citations). Charles Link has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Nicholas N. Vahanian, Richard K. Burt, Hyo S. Han, Roohi Ismail‐Khan, Hatem Soliman, Daniel M. Sullivan, Scott Antonia, Susan Minton, Larissa Verda and Yu Oyama. Their work appears in journals such as Cancer Research, Oncotarget, Neuro-Oncology, European Journal of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.